12:00 AM
 | 
Feb 20, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Verifi prenatal test: Pivotal trial data

Top-line data from the prospective, blinded, U.S. MELISSA validation trial in 532 maternal blood samples showed that Verinata's verifi prenatal test had 100% sensitivity and 100% specificity for detecting fetal trisomy 21 Down syndrome; 97.3% sensitivity and 100% specificity for detecting fetal trisomy 18 Edwards syndrome; 78.6% sensitivity and 100% specificity for detecting fetal...

Read the full 250 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >